North America Defibrillators Market to Reach $8.1 Billion by 2023

  • Published: December 2018

The North American defibrillators market is expected to reach $8.1 billion by 2023, according to P&S Intelligence.

Surging geriatric population, rising incidence of cardiac diseases, and growing demand for automated external defibrillators (AEDs) are some of the key factors driving the market growth.

Insights into the market segments

External defibrillators and implantable cardioverter defibrillators (ICDs) are the two products in the North American defibrillators market. The ICD category is further bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). Among these two, T-ICD is expected to be the faster growing category in this market, advancing at a CAGR of 4.3% during the forecast period.

North America Defibrillators Market

In terms of volume, more than one million units of ICDs are expected to be sold by 2023. This can be attributed to the increasing incidence of sudden cardiac arrests (SCAs), development of technologically advanced ICDs, and growing adoption of S-ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds).

The report further classifies the North American T-ICDs market into CRT-Ds, dual-chamber ICDs, and single-chamber ICDs. The market for CRT-Ds is expected to generate $2.0 billion revenue by 2023, mainly on account of the increasing demand for CRT-Ds for the treatment of advanced heart failure.

Among the various external defibrillators available in the North American defibrillators market, automated external defibrillator (AED) is expected to lead the market, in terms of size as well as growth, in the coming years. This category is expected to grow at the fastest CAGR of 5.9% during the forecast period.

On the basis of end user, the North American defibrillators market is categorized into hospitals, clinics, and cardiac centers; public access settings; pre-hospital care settings; and home care settings. Public access settings as an end-user category is expected to observe fastest growth at a CAGR of 5.5% during the forecast period.

Browse report overview with 95 tables and 48 figures spread through 134 pages and detailed TOC on "North America Defibrillators Market by Product (ICDs [T-ICDs {CRT-Ds, Single-Chamber Defibrillators, Dual-Chamber Defibrillators}, S-ICDs], External Defibrillators [AEDs {Semi-Automated, Fully Automated}, Manual Defibrillators, Wearable Cardioverter Defibrillators]), by End User (Hospitals, Clinics, & Cardiac Centers, Pre-Hospital Care Settings, Public Access Settings, Home Care Settings), by Geography (U.S., Canada) – Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at:

Growing Focus on the Installation of Defibrillators in Public Places is a Notable Trend Observed in the North American Defibrillators Market

Given the growing awareness about the life-saving potential of defibrillators in case of emergencies, the installation of these devices is increasing in public places such as train stations, schools and colleges, shopping centers, airports, malls, and leisure centers. These defibrillators are also known as public access defibrillators (PADs), as they can be used by anyone during an emergency.

Several organizations in the U.S. are taking initiatives to install PADs in their vicinities. For example, in February 2016, the Sudden Cardiac Arrest Foundation, a national community-benefit organization in the U.S., granted funds to several schools for the procurement of AEDs through its “You Can Save a Life at School AED Grant” program.

Defibrillators Market in Canada to Witness Considerable Growth in the Coming Years

In terms of value, the Canadian defibrillators market is predicted to grow at a CAGR of 4.3% during the forecast period. Increasing government support in the form of funding and initiatives to increase awareness and provide training on defibrillation; presence of a large number of local suppliers; and rising number of SCA cases have boosted the demand for defibrillators in Canada in the last few years.

The report also provides insights into regulatory scenario, pricing analysis of various types of defibrillators available in the North American market, and reimbursement polices related to these products.

The key players in the North American defibrillators market are Koninklijke Philips N.V., Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Medtronic plc, BIOTRONIK SE & Co. KG, SCHILLER AG, Asahi Kasei Corporation, Defibtech LLC and Cardiac Science Corporation.


By Product

  • Implantable Cardioverter Defibrillators (ICDs)
    • Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
      • Cardiac resynchronization therapy defibrillators (CRT-Ds)
      • Dual-chamber ICDs
      • Single-chamber ICDs
    • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
  • External Defibrillators
    • Automated defibrillators
      • Fully automated defibrillators
      • Semi-automated defibrillators
    • Manual defibrillators
    • Wearable cardioverter defibrillators

By End User

  • Hospitals, Clinics, and Cardiac Centers
  • Public Access Settings
  • Pre-Hospital Care Settings
  • Home Care Settings

By Geography

  • U.S. Defibrillators Market
    • By product
    • By end user
  • Canada Defibrillators Market
    • By product
    • By end user